by J.K. Wong, H.S. Mayberg, D.D. Wang, R.M. Richardson, C. Halpern, L. Krinke, M. Arlotti, L. Rossi, A. Priori, S. Marceglia, R. Gilron, J. Cavanagh, J. Judy, S. Miocinovic, A. Devergnas, R.V. Sillitoe, S. Oehrn C.R. Cernera, A. Gunduz, W. Goodman, E. Petersen, H.M. Bronte-Stewart, R.S. Raike, M. Malekmohammadi, D. Greene, P. Heiden, H. Tan, J. Volkmann, V. Voon, L. Li, P. Sah, Y. Coyne, P.A. Silburn, C. Kubu, A. Wexler, J.A. Chandler, N.A. Provenza, S.R. Heilbronner, M. San Luciano, C.J. Rozell, M.D. Fox, C. de Hemptinne, J. Henderson, S.A. Sheth and M.S. Okun
Abstract:
The deep brain stimulation (DBS) Think Tank X was held on August 17-19, 2022 in Orlando FL. The session organizers and moderators were all women with the theme women in neuromodulation. Dr. Helen Mayberg from Mt. Sinai, NY was the keynote speaker. She discussed milestones and her experiences in developing depression DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging DBS technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank X speakers was that DBS has continued to expand in scope however several indications have reached the ‘trough of disillusionment.’ DBS for depression was considered as ‘re-emerging’ and approaching a slope of enlightenment. DBS for depression will soon re-enter clinical trials. The group estimated that globally more than 244,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, closed loop DBS, DBS tele-health, neuroethics, lesion therapy, interventional psychiatry and adaptive DBS.
Reference:
Proceedings of the 10th Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Interventional Psychiatry and Women in NeuromodulationJ.K. Wong, H.S. Mayberg, D.D. Wang, R.M. Richardson, C. Halpern, L. Krinke, M. Arlotti, L. Rossi, A. Priori, S. Marceglia, R. Gilron, J. Cavanagh, J. Judy, S. Miocinovic, A. Devergnas, R.V. Sillitoe, S. Oehrn C.R. Cernera, A. Gunduz, W. Goodman, E. Petersen, H.M. Bronte-Stewart, R.S. Raike, M. Malekmohammadi, D. Greene, P. Heiden, H. Tan, J. Volkmann, V. Voon, L. Li, P. Sah, Y. Coyne, P.A. Silburn, C. Kubu, A. Wexler, J.A. Chandler, N.A. Provenza, S.R. Heilbronner, M. San Luciano, C.J. Rozell, M.D. Fox, C. de Hemptinne, J. Henderson, S.A. Sheth and M.S. Okun. Frontiers in Human Neuroscience, vol. 16, January 2023.
Bibtex Entry:
@article{wong.23,
author = {Wong, J.K. and Mayberg, H.S. and Wang, D.D. and Richardson, R.M. and Halpern, C. and Krinke, L. and Arlotti, M. and Rossi, L. and Priori, A. and Marceglia, S. and Gilron, R. and Cavanagh, J. and Judy, J. and Miocinovic, S. and Devergnas, A. and Sillitoe, R.V. and Cernera, S. Oehrn, C.R. and Gunduz, A. and Goodman, W. and Petersen, E. and Bronte-Stewart, H.M. and Raike, R.S. and Malekmohammadi, M. and Greene, D. and Heiden, P. and Tan, H. and Volkmann, J. and Voon, V. and Li, L. and Sah, P. and Coyne, Y. and Silburn, P.A. and Kubu, C. and Wexler, A. and Chandler, J.A. and Provenza, N.A. and Heilbronner, S.R. and San Luciano, M. and Rozell, C.J. and Fox, M.D. and de Hemptinne, C. and Henderson, J. and Sheth, S.A. and Okun, M.S.},
title = {Proceedings of the 10th Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Interventional Psychiatry and Women in Neuromodulation},
year = 2023,
month = jan,
volume = 16,
journal = {Frontiers in Human Neuroscience},
abstract = {The deep brain stimulation (DBS) Think Tank X was held on August 17-19, 2022 in Orlando FL. The session organizers and
moderators were all women with the theme women in neuromodulation. Dr. Helen Mayberg from Mt. Sinai, NY was the keynote
speaker. She discussed milestones and her experiences in developing depression DBS. The DBS Think Tank was founded in 2012 and
provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current
and emerging DBS technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank X
speakers was that DBS has continued to expand in scope however several indications have reached the ‘trough of disillusionment.’
DBS for depression was considered as ‘re-emerging’ and approaching a slope of enlightenment. DBS for depression will soon
re-enter clinical trials. The group estimated that globally more than 244,000 DBS devices have been implanted for neurological and
neuropsychiatric disorders. This year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia
and Australia; cutting-edge technologies, closed loop DBS, DBS tele-health, neuroethics, lesion therapy, interventional psychiatry and
adaptive DBS.},
doi = {https://doi.org/10.3389/fnhum.2022.1084782}
}